Analyst Ratings For NYSE:GSK – GlaxoSmithKline (NYSE:GSK)
Today, DZ Bank reiterated its Buy rating on NYSE:GSK – GlaxoSmithKline (NYSE:GSK).
Some recent analyst ratings include
- 6/14/2018-DZ Bank Reiterated Rating of Buy.
- 4/9/2018-Deutsche Bank Reiterated Rating of Neutral.
- 4/4/2018-BNP Paribas Upgrade from a “Neutral ➝ Outperform” rating to a “” rating.
- 3/22/2018-Morgan Stanley Upgrade from a “Underweight ➝ Equal Weight” rating to a “” rating.
- 2/15/2018-Cowen Reiterated Rating of Hold.
- 2/9/2018-Kepler Capital Markets Upgrade from a “Reduce ➝ Hold” rating to a “” rating.
- 2/5/2018-JPMorgan Chase & Co. Reiterated Rating of Neutral.
Dividend information for NYSE:GSK – GlaxoSmithKline (NYSE:GSK)
NYSE:GSK – GlaxoSmithKline (NYSE:GSK) pays an annual dividend of $2.10 with a yield of 5.01% and an average dividend growth of -8.90% based on a 3 Year Average..
Dividend History for NYSE:GSK – GlaxoSmithKline (NYSE:GSK)
- On 4/26/2018 NYSE:GSK – GlaxoSmithKline announced a quarterly dividend of $0.5298 5.27% with an ex dividend date of 5/10/2018 which will be payable on 7/12/2018.
- On 2/7/2018 NYSE:GSK – GlaxoSmithKline announced a Quarterly dividend of $0.6330 6.48% with an ex dividend date of 2/22/2018 which will be payable on 4/12/2018.
- On 10/26/2017 NYSE:GSK – GlaxoSmithKline announced a quarterly dividend of $0.5037 5.51% with an ex dividend date of 11/9/2017 which will be payable on 1/11/2018.
- On 7/26/2017 NYSE:GSK – GlaxoSmithKline announced a Quarterly dividend of $0.4910 4.88% with an ex dividend date of 8/9/2017 which will be payable on 10/12/2017.
- On 4/26/2017 NYSE:GSK – GlaxoSmithKline announced a quarterly dividend of $0.4830 4.79% with an ex dividend date of 5/10/2017 which will be payable on 7/13/2017.
- On 2/8/2017 NYSE:GSK – GlaxoSmithKline announced a quarterly dividend of $0.5710 5.76% with an ex dividend date of 2/22/2017 which will be payable on 4/13/2017.
- On 10/26/2016 NYSE:GSK – GlaxoSmithKline announced a dividend of $0.4590 with an ex dividend date of 11/2/2016 which will be payable on 1/12/2017.
Recent Insider Trading Activity For NYSE:GSK – GlaxoSmithKline (NYSE:GSK)
NYSE:GSK – GlaxoSmithKline (NYSE:GSK) has insider ownership of 10.00% and institutional ownership of 11.09%.
- On 11/6/2017 Plc Glaxosmithkline, Major Shareholder, bought 428,571 with an average share price of $14.00 per share and the total transaction amounting to $5,999,994.00.
- On 10/24/2016 Plc Glaxosmithkline, Major Shareholder, bought 66,500 with an average share price of $14.00 per share and the total transaction amounting to $931,000.00.
Recent Trading Activity for NYSE:GSK – GlaxoSmithKline (NYSE:GSK)
Shares of NYSE:GSK – GlaxoSmithKline closed the previous trading session at 41.91 up +0.76 1.86% with 41.849998474121094 shares trading hands.